Thornberry Nancy — SEC Form 4 filings
SEC reporting owner CIK 1797826. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-04.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-05-03 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 11,439 shares, $261,929 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 10,824 shares @ $22.85 ($247,328) in Denali Therapeutics Inc., filed 2026-09-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | Director | 4 | — | 2 legs · 11,439 sh · $261,929 | 6 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | Director | 3 | — | — | 8 |
| Schrodinger, Inc. (SDGR) | Director | 3 | — | — | 6 |
Form 4 filings — Thornberry Nancy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-04 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 10,824 @ $22.85 · Sale (S): 615 @ $23.74 | EDGAR |
| 2026-06-23 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 472 @ $0 · Disposition to issuer (D): 398 · Grant/award (A): 1,433 (derivative) @ $0 · Grant/award (A): 398 (derivative) | EDGAR |
| 2025-06-20 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 6,037 @ $0 · Grant/award (A): 18,111 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 398 @ $0 · Grant/award (A): 1,199 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 5,000 @ $0 · Grant/award (A): 8,550 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 5,967 @ $0 · Grant/award (A): 17,901 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 501 @ $0 · Grant/award (A): 1,571 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1797826 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →